ATE65403T1 - Pharmazeutischer stoff fuer die foerderung der wiederherstellung der haematopoietischen faehigkeit. - Google Patents

Pharmazeutischer stoff fuer die foerderung der wiederherstellung der haematopoietischen faehigkeit.

Info

Publication number
ATE65403T1
ATE65403T1 AT87100811T AT87100811T ATE65403T1 AT E65403 T1 ATE65403 T1 AT E65403T1 AT 87100811 T AT87100811 T AT 87100811T AT 87100811 T AT87100811 T AT 87100811T AT E65403 T1 ATE65403 T1 AT E65403T1
Authority
AT
Austria
Prior art keywords
human
promoting
csf
haematopoietic
restoration
Prior art date
Application number
AT87100811T
Other languages
English (en)
Inventor
Masahiko Tamura
Kunihiro Hattori
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11745897&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE65403(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE65403T1 publication Critical patent/ATE65403T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT87100811T 1986-01-22 1987-01-21 Pharmazeutischer stoff fuer die foerderung der wiederherstellung der haematopoietischen faehigkeit. ATE65403T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1028086 1986-01-22
EP87100811A EP0230980B2 (de) 1986-01-22 1987-01-21 Pharmazeutischer Stoff für die Förderung der Wiederherstellung der hämatopoietischen Fähigkeit

Publications (1)

Publication Number Publication Date
ATE65403T1 true ATE65403T1 (de) 1991-08-15

Family

ID=11745897

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87100811T ATE65403T1 (de) 1986-01-22 1987-01-21 Pharmazeutischer stoff fuer die foerderung der wiederherstellung der haematopoietischen faehigkeit.

Country Status (5)

Country Link
EP (1) EP0230980B2 (de)
AT (1) ATE65403T1 (de)
CA (1) CA1297004C (de)
DE (1) DE3771509D1 (de)
ES (1) ES2039209T5 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5718893A (en) * 1984-04-15 1998-02-17 Foster; Preston F. Use of G-CSF to reduce acute rejection
EP0565722A1 (de) * 1990-12-25 1993-10-20 Kyowa Hakko Kogyo Co., Ltd. Pharmazeutische zubereitung zur pernasalen verabreichung
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US5536495A (en) * 1994-04-15 1996-07-16 Foster; Preston F. Use of G-CSF to reduce acute rejection
WO1998006422A1 (en) 1996-08-13 1998-02-19 Fujisawa Pharmaceutical Co., Ltd. Hematopoietic stem cell proliferating agents
DE19860801A1 (de) * 1998-12-30 2000-07-06 Rhein Biotech Proz & Prod Gmbh Rekombinanter Wachstumsfaktor mit der biologischen Aktivität eines G-CSF (Granulocyte Colony Stimulating Factor)
US6646110B2 (en) 2000-01-10 2003-11-11 Maxygen Holdings Ltd. G-CSF polypeptides and conjugates
US6555660B2 (en) 2000-01-10 2003-04-29 Maxygen Holdings Ltd. G-CSF conjugates
US6831158B2 (en) 2000-01-10 2004-12-14 Maxygen Holdings Ltd. G-CSF conjugates
WO2001079444A2 (en) 2000-04-12 2001-10-25 Human Genome Sciences, Inc Albumin fusion proteins
US8435939B2 (en) 2000-09-05 2013-05-07 Biokine Therapeutics Ltd. Polypeptide anti-HIV agent containing the same
BR0211071A (pt) 2001-07-11 2004-12-21 Maxygen Holdings Ltd Conjugado polipeptìdico apresentando atividade de g-csf, método para preparar um conjugado de g-csf, composição, método para tratar um mamìfero sofrendo de um nìvel neutrofìlico insuficiente, e, uso do conjugado polipeptìdico
EP2277888A3 (de) 2001-12-21 2011-04-27 Human Genome Sciences, Inc. Fusionsprotein von Albumin und Erythropoietin
ES2403932T3 (es) 2002-08-27 2013-05-22 Biokine Therapeutics Ltd. Antagonista de CXCR4 y uso del mismo
EP1594530A4 (de) 2003-01-22 2006-10-11 Human Genome Sciences Inc Albuminfusionsproteine
RU2007149238A (ru) 2005-06-01 2009-07-20 Максиджен Холдингз Лтд. (Ky) Пегилированные полипептиды гксф и способы их получения
EP2759302A3 (de) 2006-12-21 2014-11-05 Biokine Therapeutics LTD. 4F-benzoyl-TN14003 kombiniert mit Rituximab für die Verwendung in der Behandlung eines Tumors
US9155780B2 (en) 2009-02-11 2015-10-13 Yeda Research And Development Co. Ltd. Short beta-defensin-derived peptides
EP2442822B1 (de) 2009-06-14 2014-03-05 Biokine Therapeutics Ltd. Peptidtherapie zum steigern der blutplättchenwerte
WO2013160895A1 (en) 2012-04-24 2013-10-31 Biokine Therapeutics Ltd. Peptides and use thereof in the treatment of large cell lung cancer
DE102014001250C5 (de) 2014-02-03 2021-07-29 Carl Freudenberg Kg Fensterwischer
BR112018000903A2 (pt) 2015-07-16 2018-09-11 Biokine Therapeutics Ltd. composições e métodos para o tratamento de câncer
ES2830726T3 (es) 2016-02-23 2021-06-04 Biolinerx Ltd Método para seleccionar un régimen de tratamiento para la leucemia mieloide aguda (LMA)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61227526A (ja) * 1984-07-25 1986-10-09 Chugai Pharmaceut Co Ltd 新規なコロニー刺激因子
ATE65798T1 (de) * 1985-02-08 1991-08-15 Chugai Pharmaceutical Co Ltd Menschlicher granuloxcyt-koloniestimulierungsfaktor.

Also Published As

Publication number Publication date
EP0230980B2 (de) 1996-03-20
ES2039209T3 (es) 1993-09-16
EP0230980B1 (de) 1991-07-24
EP0230980A3 (en) 1988-07-27
DE3771509D1 (de) 1991-08-29
EP0230980A2 (de) 1987-08-05
ES2039209T5 (es) 1996-07-16
CA1297004C (en) 1992-03-10

Similar Documents

Publication Publication Date Title
ATE65403T1 (de) Pharmazeutischer stoff fuer die foerderung der wiederherstellung der haematopoietischen faehigkeit.
DE3683430D1 (de) Einen menschlichen granulozytkoloniereizfaktor fuer die behandlung von leukopenien enthaltende pharmazeutische zubereitung.
ES8609365A1 (es) Un factor estimulante de colonias (csf)
ATE74272T1 (de) Pharmazeutischer stoff fuer die behandlung von myelogener leukaemie.
DE69333321D1 (de) Verwendung eines Consensus-Interferons zur Reduzierung der Nebeneffekte in der Interferon Behandlung von viralen Hepatiten.
ATE227587T1 (de) Kombinierte verwendung von hyaluronsäure und therapeutischen wirkstoffen zur verbesserung des therapeutischen effekts
IL78553A (en) Therapeutic compositions of phosphonylmethoxyalkyl adenines
EP0177910A3 (de) Verwendung von Interferon-gamma (IFN-gamma) enthaltenden Präparationen zur systemischen Behandlung von verschiedenen Erkrankungen des Menschen in niedriger Dosierung
DK85786D0 (da) Biologisk aktive fragmenter af human antihaemofilisk faktor og fremgangsmaade til fremstilling deraf
EP0151989A3 (en) Means for the treatment of cardiac diseases
NZ281482A (en) The stimulation of erythropoiesis using thrombopoietin and erythropoietin
OA09317A (fr) "Utilisation d'un polypeptide ayant l'activité de l'interleukine 2 humaine pour la préparation de compositions pharmaceutiques destinées au traitement des leucémies".
DK12990D0 (da) Human granulocyt-makrofag-kolonistimulerende faktor og muteiner heraf
NZ224116A (en) Compositions of interleukin-2 and fk565; method of stimulation of the immune system and package
DE3771584D1 (de) Zusammensetzungen und anwendung von interleukin-2 und/oder interferon-beta und des tumor-necrosis-faktors fuer eine kombinationstherapie oder zur herstellung von arzneimitteln oder formulierungen.
IT8767494A0 (it) Composizione liquida per il trattamento preventivo e curativo di malattie crittogamiche di tipo oidio e procedimento per la messa in opera di tale composizione
NO873437L (no) Human placenta angiogen faktor i stand til aa stimulere kapillaer endotelcelle-proteasesyntese, dna-syntese og migrasjon.
ES8603270A1 (es) Procedimiento para preparar liposomas que contiene alergenoso fracciones de alergenos inhalables
ATA269387A (de) Pharmazeutisches mittel zur förderung und stimulierung des haarwachstums und zur verringerung von haarausfall auf basis von pyrimidinderivaten, sowie verwendung des mittels
IL84080A0 (en) Human leukocyte interferon compositions for skin treatment
DE69919969D1 (de) Humanes Wachstumshormon zur Stimulierung der Hämatopoese und der Immunrekonstitution nach hämatopoetischer Stammzelltransplantation beim Menschen
ATE66375T1 (de) Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur systemischen behandlung von verschiedenen erkrankungen des menschen in niedriger dosierung.
ATE206056T1 (de) Therapeutisches agens für neutropenie
KR100908628B1 (ko) Ｇ-ｃｓｆ를 유효성분으로 하는 외상성 말초신경 손상 치료용 조성물
JPS5559111A (en) Biological medicine for stimulating life activity of vital body and its manufacture

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time